Canine leishmaniosis (CanL) due to Leishmania infantum is a life threatening zoonotic
disease with a wide distribution in four continents and importance also in non-endemic …

The LeishVet group has formed recommendations designed primarily to help the veterinary
clinician in the management of canine leishmaniosis. The complexity of this zoonotic …

Recent research has provided new insights on the epidemiology, pathology and
immunology of canine leishmaniosis (CanL) and its genetic basis. The prevalence of …

Canine leishmaniasis (CanL) caused by Leishmania infantum (syn. L. chagasi, in Latin
America), which is transmitted by the bite of phlebotomine sand flies, is endemic and affects …

Human visceral leishmaniasis (VL) and canine visceral leishmaniasis (CVL) are the most
important emerging diseases with high prevalence in Latin American countries and are …

Background Various factors contribute to the urbanization of the visceral leishmaniasis (VL),
including the difficulties of implementing control measures relating to the domestic reservoir …

Human vaccination against leishmaniasis using live Leishmania was used in Middle East
and Russia (1941–1980). First-generation vaccines, composed by killed parasites induce …

Canine leishmaniosis (CanL) is a vector-borne disease caused by the protozoan
Leishmania (Leishmania) infantum species [syn. L.(L.) infantum chagasi species in the …

This article reviews essential topics of canine visceral leishmaniasis (CVL) due to
Leishmania infantum infection. It focuses on the current serological and molecular …

Canine leishmaniosis (CanL) is caused by the parasite Leishmania infantum and is a
systemic disease, which can present with variable clinical signs, and clinicopathological …